M. Cooper

Molecular Biology · New England Journal of Medicine · 2000–2020

A researcher in the Science corpus: 17 papers; trusts 6 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom M. Cooper trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Alejandro Rabinstein
  2. M. Zile

Who trusts M. Cooper overall

  1. V. Basevi
  2. Giuseppe Remuzzi
  3. Habib Yaribeygi

Papers from M. Cooper's perspective

Ordered by how strongly the researchers M. Cooper trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study (British medical journal)
  2. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. (American Journal of Pathology)
  3. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. (Diabetes)
  4. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. (Proceedings of the National Academy of Sciences of the United States of America)
  5. Effects of Intensive Glucose Lowering in Type 2 Diabetes
  6. Molecular motors
  7. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (New England Journal of Medicine)
  8. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370… (The Lancet)
  9. Epigenetics in cancer. (Carcinogenesis)
  10. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy (Nature Medicine)

Their papers